PHARMAC is seeking feedback on a provisional agreement with Orion Laboratories (NZ) Limited. In summary, this proposal is to list lidocaine 4% cream (30 g pack) and lidocaine 4% cream (5 g x 5 pack) from 1 August 2015:

• in Section B of the Pharmaceutical Schedule, subject to the same Special Authority criteria that currently apply to lidocaine 2.5% with prilocaine 2.5% cream (EMLA); and
• in Part II of Section H of the Pharmaceutical Schedule with no restrictions.

For more details, go to: http://www.pharmac.health.nz/news/2015-05-12-consultation-proposal-to-list-lidocaine-4-cream/